Boji Medical Technology Co.,Ltd.

Equities

300404

CNE100001Y00

Biotechnology & Medical Research

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 09/05/2024 BST			5-day change	1st Jan Change
8.07 ^CNY	-4.50%		+4.40%	-9.83%

04-25	Boji Medical Technology Co., Ltd. Announces Profit Distribution Proposal for 2023	CI
04-24	Boji Medical Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Boji Medical Technology Co., Ltd. Announces Profit Distribution Proposal for 2023

April 24, 2024

Boji Medical Technology Co. Ltd. announced on 26 April 2023 the profit distribution proposal for 2023. For the period the company proposed cash dividend per 10 shares (tax included) of CNY 0.10000000.

Latest news about Boji Medical Technology Co.,Ltd.

Boji Medical Technology Co., Ltd. Announces Profit Distribution Proposal for 2023	04-24	CI
Boji Medical Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-24	CI
Boji Medical Technology Inks 70 Million Yuan Technical Services Deal With Ruianbo Pharmaceutical Technology	04-08	MT
Boji Medical Technology's Unit Gets Nod to Market Erectile Dysfunction Tablets	03-12	MT
Tranche Update on Boji Medical Technology Co.,Ltd.'s Equity Buyback Plan announced on February 6, 2024.	03-04	CI
Boji Medical Technology Co.,Ltd.'s Equity Buyback announced on February 6, 2024, has closed with 2,667,000 shares, representing 0.72% for CNY 15.10 million.	02-29	CI
Boji Medical Technology Bags 107.7 Million Yuan Clinical Trial Assistance Deal; Shares Surge 20%	02-20	MT
Boji Medical Technology Co., Ltd. announces an Equity Buyback for CNY 20 million worth of its shares.	02-05	CI
Boji Medical Technology Co., Ltd. authorizes a Buyback Plan.	02-04	CI
Boji Medical Scores 54 Million Yuan Contract For Eye Drop Clinical Trial Research	01-26	MT
Boji Medical Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23	CI
Boji Medical Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	25/08/23	CI
Boji Medical Technology Co., Ltd. Approves the Election of Directors and Non-Employee Supervisors	03/08/23	CI
Boji Medical Technology Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 11 July 2023	04/07/23	CI
Boji Medical Technology Co., Ltd. Proposes Cash Dividend for 2022	26/04/23	CI
Boji Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	25/04/23	CI
Boji Medical Technology Gets Warning for Disclosure Breaches; Shares Jump 7%	28/02/23	MT
Boji Medical’s Chairman to Boost Stake to 39% After 84 Million Yuan Deal; Shares Rally 14%	16/02/23	MT
Boji Medical Technology Co., Ltd. announced that it expects to receive CNY 83.999999 million in funding	13/02/23	CI
Boji Medical Signs 55.5 Million Yuan Deal to Complete Trial of Therapeutic Drug	28/12/22	MT
Boji Medical Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	26/10/22	CI
Boji Medical Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	25/08/22	CI
Boji Medical Technology Co., Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date Is 02 June 2022	26/05/22	CI
Boji CRO Approves Cash Dividend for the Year 2021	18/05/22	CI
Boji Medical Technology Co., Ltd. Proposes Final Cash Dividend for 2021	26/04/22	CI

Chart Boji Medical Technology Co.,Ltd.

Duration

Period

More charts

Company Profile

Boji Medical Technology Co Ltd is a China-based company that provides Contract Research Organization (CRO) services. The Company mainly provides one-stop CRO services for the development and production of new drugs and medical devices for domestic and foreign pharmaceutical companies and other research institutions. The Company's CRO services include pre-clinical research services, clinical research services, other consulting services, pharmaceutical Contract Development Manufacture Organization (CDMO) services, pre-clinical independent research and development services, and technology achievement transformation services. The Company mainly conducts its businesses in the domestic market.

Sector

Biotechnology & Medical Research

Calendar

16/05/2024 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

8.07 CNY

Average target price

11.74 CNY

Spread / Average Target

+45.48%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
BOJI MEDICAL TECHNOLOGY CO.,LTD.	-9.83%	424M
MODERNA, INC.	+17.96%	44.96B
IQVIA HOLDINGS INC.	+1.17%	42.65B
LONZA GROUP AG	+48.77%	41.85B
CELLTRION, INC.	-4.27%	29.04B
ICON PUBLIC LIMITED COMPANY	+11.42%	26.08B
ALNYLAM PHARMACEUTICALS, INC.	-21.39%	19.03B
BIO-TECHNE CORPORATION	+4.86%	12.75B
MEDPACE HOLDINGS, INC.	+27.29%	12.06B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.50%	11.75B

Other Biotechnology & Medical Research